Citius Pharmaceuticals, Inc. Deferred Income Tax Liabilities, Net
Citius Pharmaceuticals, Inc. (CTXR) had Deferred Income Tax Liabilities, Net of $7.70 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-14
- 2026-06-30: Deferred Income Tax Liabilities, Net $7.70M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $7.80M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $8.04M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $7.77M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $7.70M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $7.80M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $8.04M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $7.77M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $7.51M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $7.24M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $6.98M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $6.71M 10-K · filed 2025-12-23 |
| 2024-06-30 | $6.57M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $6.43M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.28M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $6.14M 10-K · filed 2024-12-27 |
| 2023-06-30 | $5.99M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.85M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $5.71M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $5.56M 10-K · filed 2023-12-29 |
| 2022-06-30 | $4.99M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.99M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $4.99M 10-K · filed 2022-12-22 |
| 2021-06-30 | $4.99M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.99M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.99M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $4.99M 10-K · filed 2021-12-15 |
| 2020-06-30 | $4.99M 10-Q · filed 2020-08-14 |
| 2019-09-30 | $4.99M 10-K · filed 2020-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |